Sorted By:

Relevance


Nearly 200 Medicines in Development for Arthritis and Related Disorders, The Nation’s Most Common Cause of Disability

PhRMA  |  Press Release

  “Globally, millions of patients and healthcare professionals hope for better treatments to help ease the pain and suffering caused by arthritis and other musculoskeletal disorders,” said PhRMA President and CEO John J.
https://www.phrma.org/press-release/nearly-200-medicines-in-development-for-arthritis-and-related-disorders-the-nation-s-most-common-cause-of-disability

PhRMA Statement on Clinical Trials, Research Collaborations and Washington Post Article

PhRMA  |  Press Release

“The biopharmaceutical sector is proud of our commitment to science and the over 300 new medicines that have been approved over the last decade – and the 3,200 in the pipeline today.
https://www.phrma.org/press-release/phrma-statement-on-clinical-trials-research-collaborations-and-washington-post-article

Time to enforce the rules that protect American ideas, brands and inventions

PhRMA  |  Blog Post

They appear to be inconsistent with commitments Canada and India made in the WTO and highlight the urgent need to ensure America’s trading partners live up to their international obligations.
http://catalyst.phrma.org/time-to-enforce-the-rules-that-protect-american-ideas-brands-and-inventions

Medicare Monday: What they’re saying about the CMS proposed Part B payment model

PhRMA  |  Blog Post

Also, rheumatologists argue that factoring in the Part B demonstration would distort physician comparisons in the Merit-Based Incentive Payment System, which will also be part of the new physician-pay scheme,” reports Inside Health Policy.
http://catalyst.phrma.org/medicare-monday-what-theyre-saying-about-the-cms-proposed-part-b-payment-model

Ask About Adherence: PhRMA Foundation Young Investigator Adherence Grant Program

PhRMA  |  Blog Post

But, this week we are straying from our regular format to announce that the PhRMA Foundation has awarded four research grants as part of its Young Investigator Adherence Grant Program.
http://catalyst.phrma.org/ask-about-adherence-–-phrma-foundation-young-investigator-adherence-grant-program

IMS Health Report Finds Medicines Helping Bend the Health Care Cost Curve

PhRMA  |  Press Release

Unlike medicines, health plans do not single out the sickest patients by requiring higher rates of cost-sharing for costly hospital stays or other health care services, even though the financial risk associated with medical spending is generally considerably higher than it is for medicines.
https://www.phrma.org/press-release/ims-health-report-finds-medicines-helping-bend-the-health-care-cost-curve

Industry Support for Exempting FDA User Fees from Sequestration

PhRMA  |  Press Release

It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology.
https://www.phrma.org/press-release/industry-support-for-exempting-fda-user-fees-from-sequestration

Medicare Monday: New research finds trends in Average Sales Price of Part B drugs remains stable

PhRMA  |  Blog Post

In fact, when comparing volume-weighted ASP to the Consumer Price Index for Medical Care, the analysis found that price growth for Medicare Part B drugs is below overall medical inflation.
http://catalyst.phrma.org/medicare-monday-new-research-finds-trends-in-average-sales-price-of-part-b-drugs-remains-stable

Australia’s opportunity to lead the TPP forward

PhRMA  |  Blog Post

However, three recent articles have made a very strong case for Australia strengthening IP to provide the necessary regulatory data protection that will help the cause of medial innovation.
http://catalyst.phrma.org/australia-s-opportunity-to-lead-the-tpp-forward

PhRMA’s Rick Smith Testifies Before the Senate Aging Committee

PhRMA  |  Press Release

For example, CBO cited Harvard research that found in 2011 that the implementation of Part D was associated with a $1,200 average reduction in nondrug medical spending for Medicare beneficiaries with limited prior drug coverage.
https://www.phrma.org/press-release/phrma-s-rick-smith-testifies-before-the-senate-aging-committee

PhRMA Member Companies Invested $51.2 Billion in R&D in 2014

PhRMA  |  Blog Post

What these figures demonstrate is that the commitment of America’s biopharmaceutical companies to solving the world’s most vexing medical challenges has never been more resolute.
http://catalyst.phrma.org/phrma-member-companies-invested-51.2-billion-in-rd-in-2014

A Big Step Forward in Patent Reform

PhRMA  |  Blog Post

Read our official statement on the passage of the America Invents Act.
http://catalyst.phrma.org/a-big-step-forward-in-patent-reform

Contact PhRMA

PhRMA  |  From PhRMA

General Contact Information Pharmaceutical Research and Manufacturers of AmericaPhRMA Headquarters950 F Street, NW Suite 300, Washington, DC 20004Phone: (202) 835-3400www.PhRMA.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA www.YouTube.com/user/PhRMAPress www.LinkedIn.com/company/phrma Media If you are a member of the media, contact the Communications & Public Affairs department.
https://www.phrma.org/contact-us

Medicines in Development: Vaccines

PhRMA  |  Press Release

To learn about the nearly 300 vaccines in development for both preventative and therapeutic uses, see PhRMA’s new Vaccines in Development report.
https://www.phrma.org/press-release/medicines-in-development-vaccines

Week in review: The latest from PhRMA

PhRMA  |  Blog Post

Medicare Monday – The Medicare Payment Advisory Commission (MedPAC) met this week to vote on a series of recommendations regarding the Part D program.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-april-8-2016

Biologics Research Promises to Bolster Future of Medicine

PhRMA  |  Press Release

The Biologic Medicines in Development report as well as an overview and other supplementary materials are available on PhRMA’s website at http://phrma.org/innovation/meds-in-development.
https://www.phrma.org/press-release/biologics-research-promises-to-bolster-future-of-medicine

Antiretroviral Treatments and Ensuing Innovations Prevent Almost 900,000 Premature HIV/AIDS Deaths

PhRMA  |  Graphic

But what would the world look like had HAART and the other medical innovations that built on HAART never been discovered?
https://www.phrma.org/graphic/antiretroviral-treatments-and-ensuing-innovations-prevent-almost-900-000-premature-hiv/aids-deaths

Growing consensus on the need to improve communications with health care professionals

PhRMA  |  Blog Post

Richard Schilsky, chief medical officer at the American Society of Clinical Oncology and a coauthor of the Duke report, said, “… sometimes only a company is aware of the full range of information that could be of benefit and should have a mechanism to convey that.
http://catalyst.phrma.org/growing-consensus-on-the-need-to-improve-communications-with-health-care-professionals

Partnership for Prescription Assistance Celebrates 10th Anniversary

PhRMA  |  Blog Post

This week the Partnership for Prescription Assistance (PPA) celebrates its 10th anniversary of connecting uninsured or underinsured Americans to programs that provide prescription medicines for free or nearly free.
http://catalyst.phrma.org/partnership-for-prescription-assistance-celebrates-10th-anniversary

Never Too Late to Plan for Retirement

PhRMA  |  Blog Post

The fact that there are no treatments today and few diagnostic tools underscores the urgency of research efforts, and makes us all hope for some progress towards a treatment or cure from one of the nearly 100 medicines now being developed to fight Alzheimer's disease.
http://catalyst.phrma.org/never-too-late-to-plan-for-retirement

PhRMA Statement on Orphan Diseases

PhRMA  |  Press Release

According to a PhRMA survey, some examples of medicines being developed for rare diseases are: a monoclonal antibody for chronic sarcoidosis, an immune system disorder; a medicine for Lennox-Gastaut syndrome, a severe form of epilepsy; a gene therapy for cystic fibrosis; and a medicine for Friedreich’s ataxia, a genetic disorder.
https://www.phrma.org/press-release/phrma-statement-on-orphan-diseases

Center for Medicare and Medicaid Innovation

PhRMA  |  From PhRMA

These can include “alternative payment models,” such as accountable care organizations, bundled payments and patient centered medical homes or more direct changes to Medicare coverage and payment.
https://www.phrma.org/advocacy/medicare/center-for-medicare-and-medicaid-innovation

Past free trade agreements provide valuable lessons for future success

PhRMA  |  Blog Post

Hatch voiced, a “full and faithful” implementation by all parties involved is key for implementing negotiations and agreements, and for all U.S. citizens to reap the benefits they provide.
http://catalyst.phrma.org/past-free-trade-agreements-provide-valuable-lessons-for-future-success

PhRMA Names Tina Stow as Vice President of Communications

PhRMA  |  Press Release

She will oversee a team responsible for the day-to-day activities associated with media relations, including message development, proactive media outreach, rapid response, message research and relationship-building with key reporters and influencers.
https://www.phrma.org/press-release/phrma-names-tina-stow-as-vice-president-of-communications

NORD on the Need for More Collaboration to Drive Progress for Rare Disease Patients

PhRMA  |  Blog Post

We see this initiative – the Medical Device Innovation Consortium – as potentially a model for collaboration in other areas of medical diagnostics and therapies.
http://catalyst.phrma.org/nord-on-the-need-for-more-collaboration-to-drive-progress-for-rare-disease-patients

You have reviewed the first 325 results out of 1046. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next